Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Misoprostol for term labor induction: a randomized controlled trial.

Gulshan A Saeed1, Shazia Fakhar, Nadia Nisar

  • 1Obstetrics and Gynecology, Shifa College of Medicine, Islamabad, Pakistan. gsaeed33@yahoo.com

Taiwanese Journal of Obstetrics & Gynecology
|April 13, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Climate change and public health research ethics in low- and middle-income countries: A systematic literature review.

The journal of climate change and health·2026
Same author

Ada'a Health Center: leading change in healthcare performance in Saudi Arabia.

BMC health services research·2026
Same author

Rare Presentation of a Viable Secondary Abdominal Ectopic Pregnancy in the Rudimentary Horn of a Bicornuate Uterus: A Case Report.

Clinical case reports·2026
Same author

The mediating role of safety behavior in the relationship between safety climate and safety outcomes among sanitary workers in Pakistan.

Frontiers in public health·2025
Same author

Exploring Safety Outcomes Among Sanitary Workers in Punjab, Pakistan.

Cureus·2025
Same author

Unraveling influenza sentinel surveillance in Pakistan 2008-2024: Epidemiological insights during the pre and post pandemic period of COVID-19.

Journal of infection and public health·2024
Same journal

Common on "Polypoid endometriosis in a young female with systemic lupus erythematosus, mimicking ovarian and pelvic malignancy, a case report".

Taiwanese journal of obstetrics & gynecology·2026
Same journal

45,X/47,XXX at amniocentesis and detection of disomy X cell line by fluorescence in situ hybridization in uncultured amniocytes and various tissues in a pregnancy with a favorable fetal outcome and perinatal decrease of the 45,X cell line.

Taiwanese journal of obstetrics & gynecology·2026
Same journal

Low-level mosaic trisomy 21 at amniocentesis in a pregnancy associated with a favorable fetal outcome and perinatal progressive decrease of the trisomy 21 cell line.

Taiwanese journal of obstetrics & gynecology·2026
Same journal

High-level mosaic trisomy 21 at amniocentesis associated with positive NIPT for trisomy 21 in a pregnancy with postnatal decrease of the trisomy 21 cell line and a favorable fetal outcome.

Taiwanese journal of obstetrics & gynecology·2026
Same journal

Low-level mosaic trisomy 15 without UPD 15 at amniocentesis associated with cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes, IUGR, preterm birth and preeclampsia in a pregnancy with a favorable fetal outcome and perinatal decrease of the trisomy 15 cell line.

Taiwanese journal of obstetrics & gynecology·2026
Same journal

Prenatal diagnosis of a familial 3p26.3p26.1 deletion in a pregnancy associated with no apparently phenotypic abnormality in the family carrier members.

Taiwanese journal of obstetrics & gynecology·2026
See all related articles

Vaginal misoprostol is an effective and cost-efficient option for term labor induction compared to dinoprostone. This randomized trial found misoprostol shortened labor and delivery intervals with comparable safety outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Medicine

Background:

  • Labor induction is a common obstetric procedure.
  • Dinoprostone is a widely used agent for labor induction.
  • Evaluating alternative induction methods is crucial for optimizing patient care.

Purpose of the Study:

  • To compare the efficacy and safety of vaginal misoprostol versus vaginal dinoprostone for term labor induction.

Main Methods:

  • A randomized controlled trial involving 200 women at term pregnancy undergoing labor induction.
  • Participants were randomized to receive either vaginal misoprostol (Group A) or vaginal dinoprostone (Group B).
  • Key outcomes included induction-delivery interval, maternal/fetal complications, and Apgar scores.

Main Results:

Related Experiment Videos

  • Vaginal misoprostol significantly reduced the mean time to labor onset (6.67 vs. 8.41 hours, p=0.00) and induction-delivery interval (11.68 vs. 15.37 hours, p=0.00) compared to dinoprostone.
  • Uterine hyperstimulation occurred in 10% of the misoprostol group versus 4% in the dinoprostone group (p=0.09), with no uterine ruptures in either group.
  • Apgar scores and other maternal/fetal complications were comparable between the groups.

Conclusions:

  • Vaginal misoprostol is an efficacious and cost-effective alternative for term labor induction.
  • The findings support re-evaluating the role of misoprostol in current obstetric practice.
  • Misoprostol offers a viable option for women requiring labor induction at term.